1. Technical Field
The present invention relates to medical therapy systems in general, including therapeutic cooling, heating, and compression systems used in association therewith, and more particularly, but not by way of limitation, to a programmable, thermal therapy and external pneumatic compression for the prevention of deep vein thrombosis.
2. Description of the Related Art
Considerable medical attention has been given to the serious medical issue of Deep Vein Thrombosis (“DVT”). One approach to the prevention of DVT has been External Pneumatic Compressions (“EPC”). EPC has been shown to be helpful as a prophylaxis for DVT, although refinements over existing systems are still in need. For example, multiple articles have been written addressing this issue, including a compilation of recommendations for preventing DVT (Heit J A: Current Recommendations for Prevention of Deep Venous Thrombosis. In: Handbook of Venous Disorders. Gloviczki P, Yao J S, eds. Cambridge, The University Press, 1996). Engineering studies are presented which also address EPC as a preventative for DVT (Kamm R D: Bioengineering Studies of Periodic External Compression as Prophylaxis Against Deep Vein Thrombosis—Part 1: Numerical Studies. J Biomech Engineering 104(1): 87-95, 1982). Such efforts are meritorious for patient health due to possible Pulmonary Embolism (“PE”) resulting from DVT (National Institutes of Health Consensus Development Conference Statement: Prevention of Venous Thrombosis and Pulmonary Embolism. JAMA 6(2) 744-749, 1986). Additionally, studies have been performed relative to DVT and orthopedic surgery (“OS”) (Westrich G H, Sculco T P: Prophylaxis Against Deep Vein Thrombosis After Total Knee Arthroplasty. J Bone Joint Surg 78-A(6): 826-834, 1996).
Relative to OS, physicians have long recognized the need to provide warmth and cooling directly to patients as part of OS therapy. Better recoveries have been reported, for example, using cold therapy for orthopedic patients. The benefits of warming patients undergoing surgery has also been demonstrated. It may also be desirable to cool portions of a patient's anatomy in certain circumstances. Yet another advantageous therapy is the application of heat then cold to certain injured areas. See, for example, U.S. Pat. No. 5,989,285 (the '285 Patent) assigned to Thermotek, Inc. and incorporated herein by reference.
Several devices have been developed that deliver temperature-controlled fluids through pads or convective thermal blankets to achieve the above thermal purpose. Typically these devices have a heating or a cooling element, a source for the fluid, a pump for forcing the fluid through the pad or blanket, and a thermal interface between the patient and the temperature-controlled fluid. U.S. Pat. No. 4,884,304 to Elkins is directed to a mattress-cover device that contains liquid flow channels that provide the selective heating or cooling by conduction.
Devices have also been developed for providing heat to a person in bed. Electric blankets containing electric heating elements have been used for years to warm a person in bed. Cooling blankets, such as the blanket disclosed in U.S. Pat. No. 4,660,388 to Greene, have also been proposed. Greene discloses a cooling cover having an inflatable pad with plenum chambers at opposite ends thereof. Cool gas is generated in a separate unit and directed to the pad and out a number of apertures on the underside of the pad and against the body of the person using the cover.
A disposable heating or cooling blanket that has three layers of flexible sheeting is disclosed in U.S. Pat. No. 5,125,238 to Ragan, et al. Two of the layers form an gas chamber and the third includes a comfortable layer for contact with the patient. Conditioned gas is directed toward the covered person through a multiplicity of orifices in the bottom layers of the blanket.
The temperature-controlled blanket and bedding assembly disclosed in the '285 Patent includes a temperature-controlled blanket and temperature-controlled bedding system that provide both recirculating temperature-controlled fluid and temperature-controlled gas to enhance performance for convectively heating or cooling a patient. Counter-flow or co-flow heat-exchanging principles between the temperature-controlled liquid and the temperature-controlled gas achieve temperature uniformity across different sections of the blanket and the bedding system. Drapes and the temperature-controlled bedding system provide a temperature-controlled envelope around a person using the bedding system. In one embodiment of the bedding system, an gas portion of the bedding system is provided that supplies a fluid portion of the overall bedding system. In another embodiment of the bedding system, the fluid portion of the bedding system is provided for use with a patient bed that supplies the gas portion of the overall bedding system.
U.S. Pat. No. 5,097,829 to Quisenberry describes an improved temperature-controlled fluid-circulating system for automatically cooling a temperature-controlled fluid in a thermal blanket with a thermoelectric-cooling device having a cold side and a hot side when powered by electricity. The temperature-controlled fluid is cooled by a cold side of the cooling device and is pumped through, to, and from the blanket through first and second conduits.
The present invention relates to thermal therapy and compression therapy for use in heating and/or cooling a patient and providing compression. In one aspect of the invention, a DVT therapy system includes at least a control unit, one or more thermal-treatment blankets, one or more compressive-therapy treatment devices, and a plurality of connector tubes. The control unit may be adapted to heat and/or cool a heat-transfer liquid within about 37-105 F and to provide compressed gas at a pressure of greater than around 25 mm Hg above ambient atmospheric pressure, but the ranges may also include lower and/or higher temperatures and pressures. The one or more thermal-treatment blankets may be adapted for receipt of the heat-transfer liquid from the control unit and for return of the heat-transfer liquid back to the control unit via the connector tubes. The one or more compressive-therapy treatment devices may be adapted to utilize the compressed gas from the control unit via connector tubes.
In another aspect, a DVT method includes providing a control unit adapted to heat and/or cool a heat-transfer liquid to a temperature within the range of about 37-105° F. and adapted to provide compressed gas at a pressure of at least 25 mmHg above ambient atmospheric pressure, providing a thermal treatment blanket adapted for receipt of the heat-transfer liquid from the control unit and for sending the heat-transfer liquid back to the control unit, and applying a hot or cold treatment to an individual. The method may also include providing a compressive-therapy treatment device utilizing the compressed gas from the control unit and applying a compressive treatment to an individual.
In another aspect, a DVT therapy method may include a method of providing sequenced thermal therapy, sequenced compression therapy, and/or DVT therapy to parts of a body. The method may include providing a control unit adapted to thermally control, such as heating and/or cooling, a heat transfer fluid and adapted to provide compressed gas, providing a thermal blanket adapted to receive the heat transfer fluid from the control unit and return the heat transfer fluid to the control unit via one or more connector tubes, and also adapted to receive the compressed gas from the control unit via one or more connector tubes, providing one or more DVT compression devices adapted to utilize the compressed gas from the control unit via one or more connector tubes, and applying the thermal treatment, the compression treatment, and the DVT treatment to the individual in multiple modalities regulated by the control unit. The multiple modalities may include sequencing and/or alternating between the treatments.
In another aspect, a DVT therapy system may include a system for providing multiple modalities of thermal therapy, compression therapy, and/or DVT therapy, and may include sequentially applying the therapies. The system may include a control unit adapted to heat and/or cool a heat-transfer liquid and to provide compression; a thermal-treatment blanket adapted to receive the heat-transfer liquid from the control unit and to send the heat-transfer liquid back to the control unit; a compressive-therapy treatment device adapted to utilize the compressed gas from the control unit; and/or a DVT treatment device adapted to utilize the compressed gas from the control.
A more complete understanding of the method and apparatus of the present invention may be obtained by reference to the following Detailed Description when taken in conjunction with the accompanying Drawings wherein:
Applicants have discovered that the use of both thermal therapy and compression therapy for the prevention of DVT may be advantageous. As referenced above, numerous articles have been written on the problems associated with DVT and the utilization of thermal therapy is already well known. Consistent therewith, methods of and systems for providing pressurized and thermally controlled fluids for use with patients in need of such therapy are disclosed. A versatile control unit is adapted for providing one of a plurality of treatment modalities. As will be described below, one modality provides a thermally controlled liquid adapted to flow through a treatment pad or blanket for thermal therapy. A second modality provides compressed gas to a treatment pad or blanket to cause a degree of compression relative to a patient. A third modality provides compressed gas to DVT therapy modules so that the prevention of DVT can be afforded. In various embodiments, each of the above modalities may be provided in a single treatment regimen.
As will be described in more detail below, a control unit is shown that is adapted to provide thermally controlled fluid and compressed gas for multiple therapeutic modalities. The control unit for providing these selective features may be enclosed within a single chassis design capable of providing the described modalities. This selective versatility provides financial and manufacturing incentives in that the simple design selectively can provide an industrial, medical, or electro-optic version that produces only thermally controlled liquid, such as co-liquid for cooling industrial equipment, in a configuration adaptable for other applications. In one embodiment, the size of the reservoir has been reduced relative to a number of earlier models of thermoelectric cooler (TEC) systems such that only around 175 Watts may be needed compared to 205 Watts for typical earlier systems. As such, the control unit may be configurable with TEC assemblies maximizing efficiency. With regard to a medical modality, thermal therapy may be afforded to a patient to reduce swelling and edema while, in conjunction with the DVT prophylaxis, preventing blood from pooling in lower body extremities. This is particularly important after surgery when anesthesia has been involved. It is well known that anesthetics often tend to reduce the wall strength of veins and, if not otherwise treated, appropriate venous pumping may not be afforded allowing for blood pooling in clots.
Referring now to
Referring still to
Referring now to
Still referring to
Referring still to
Still referring to
Referring now to
Referring now to
Referring now to
Still referring to
In various embodiments, different sequencing patterns, times, and pressures may be utilized depending on the type of treatment desired. Various embodiments allow a plurality of parameters to be specified by a user, such as, for example, the inflated pressure, the deflated pressure, the rate of inflation, the inflation-hold time, and the cycle time. For example, in one treatment modality, the control unit may provide compressed gas to inflate a DVT compression device for 3-20 seconds when the DVT compression device is disposed on a calf. The time period of the pulse may be more or less depending on the part of the body being treated. For example, a pulse width of around 0.3 seconds may be desirable for a foot. Similarly, the inflation times may vary depending on whether DVT compression devices located on both right and left extremities are being inflated simultaneously or whether the inflation is being alternated between the devices. For example, an inflation period of 18 seconds may be desirable for simultaneous inflation whereas an inflation period of 8 seconds may be desirable when the inflation is being alternated. Similarly, when DVT compression devices are disposed around a patient's right and left feet, in some situations it may be desirable to have a wide pulse width on the order of 9 seconds whereas in other situations it may be desirable to have a narrow pulse width on the order of 0.3 seconds. In addition, it may be desirable to vary the cycle times in between DVT pulses. For example, in some embodiments, a cycle time of 20 seconds in between DVT pulses may be desirable. Similarly, in some embodiments, it may be desirable to completely deflate the DVT compression devices in between inflations while in other embodiments, it may be desirable to keep the DVT compression devices partially inflated. As can be seen from the above examples, it would be desirable to have a programmable control unit that can be adapted to provide DVT compression at user-specified parameters.
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Still referring to
Referring now to
The previous description is of embodiments of the invention. The scope of the invention should not necessarily be limited by this description. The scope of the present invention is instead defined by the following claims.
The present application is a continuation of U.S. patent application Ser. No. 12/234,394, filed Sep. 19, 2008. U.S. patent application Ser. No. 12/234,394 is a continuation-in-part of U.S. patent application Ser. No. 11/733,709 filed Apr. 10, 2007. U.S. patent application Ser. No. 11/733,709 claims priority to U.S. Provisional Patent Application Nos. 60/817,932, filed Jun. 30, 2006 and 60/791,132, filed Apr. 11, 2006. U.S. patent application Ser. No. 12/234,394 is a continuation-in-part of U.S. patent application Ser. No. 10/894,369 filed Jul. 19, 2004. U.S. patent application Ser. No. 10/894,369 claims priority to U.S. Provisional Patent Application Nos. 60/588,453, filed Jul. 16, 2004; 60/550,658, filed Mar. 5, 2004; and 60/488,709, filed Jul. 18, 2003. U.S. patent application Ser. Nos. 12/234,394; 11/733,709; 10/894,369; 60/817,932; 60/791,132; 60/588,453; 60/550,658; and 60/488,709 are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3164152 | Vere Nicoll | Jan 1965 | A |
3548809 | Conti | Dec 1970 | A |
3660849 | Jonnes et al. | May 1972 | A |
3736764 | Chambers et al. | Jun 1973 | A |
3738702 | Jacobs | Jun 1973 | A |
3744053 | Parker et al. | Jul 1973 | A |
3744555 | Fletcher et al. | Jul 1973 | A |
3862629 | Rotta | Jan 1975 | A |
3894213 | Agarwala | Jul 1975 | A |
4006604 | Seff | Feb 1977 | A |
4013069 | Hasty | Mar 1977 | A |
4029087 | Dye et al. | Jun 1977 | A |
4224941 | Stivala | Sep 1980 | A |
4375217 | Arkans | Mar 1983 | A |
4402312 | Villari et al. | Sep 1983 | A |
4459468 | Bailey | Jul 1984 | A |
4459822 | Pasternack | Jul 1984 | A |
4471787 | Bentall | Sep 1984 | A |
4503484 | Moxon | Mar 1985 | A |
4547906 | Nishida et al. | Oct 1985 | A |
4590925 | Dillon | May 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
D285821 | Kneisley | Sep 1986 | S |
D288372 | Adams | Feb 1987 | S |
4660388 | Greene, Jr. | Apr 1987 | A |
4738249 | Linman et al. | Apr 1988 | A |
D295897 | Thimm-Kelly | May 1988 | S |
4821354 | Little | Apr 1989 | A |
4844072 | French et al. | Jul 1989 | A |
4884304 | Elkins | Dec 1989 | A |
4901200 | Mazura | Feb 1990 | A |
4911231 | Horne et al. | Mar 1990 | A |
4926881 | Ichinomiya et al. | May 1990 | A |
4962761 | Golden | Oct 1990 | A |
4969881 | Viesturs | Nov 1990 | A |
4979375 | Nathans et al. | Dec 1990 | A |
4989589 | Pekanmaki et al. | Feb 1991 | A |
4995698 | Myers | Feb 1991 | A |
4996970 | Legare | Mar 1991 | A |
5044364 | Crowther | Sep 1991 | A |
5051562 | Bailey et al. | Sep 1991 | A |
D320872 | McCrane | Oct 1991 | S |
5062414 | Grim | Nov 1991 | A |
5067040 | Fallik | Nov 1991 | A |
5080089 | Mason et al. | Jan 1992 | A |
5090409 | Genis | Feb 1992 | A |
5092271 | Kleinsasser | Mar 1992 | A |
5097829 | Quisenberry | Mar 1992 | A |
5106373 | Augustine et al. | Apr 1992 | A |
5112045 | Mason et al. | May 1992 | A |
5117812 | McWhorter | Jun 1992 | A |
5125238 | Ragan et al. | Jun 1992 | A |
5165127 | Nicholson | Nov 1992 | A |
5179941 | Siemssen et al. | Jan 1993 | A |
5184612 | Augustine | Feb 1993 | A |
5186698 | Mason et al. | Feb 1993 | A |
5230335 | Johnson, Jr. et al. | Jul 1993 | A |
5232020 | Mason et al. | Aug 1993 | A |
5241951 | Mason et al. | Sep 1993 | A |
5243706 | Frim et al. | Sep 1993 | A |
5263538 | Amidieu et al. | Nov 1993 | A |
5285347 | Fox et al. | Feb 1994 | A |
D345082 | Wenzl | Mar 1994 | S |
D345609 | Mason et al. | Mar 1994 | S |
D345802 | Mason et al. | Apr 1994 | S |
D345803 | Mason et al. | Apr 1994 | S |
5300101 | Augustine et al. | Apr 1994 | A |
5300102 | Augustine et al. | Apr 1994 | A |
5300103 | Stempel et al. | Apr 1994 | A |
5303716 | Mason et al. | Apr 1994 | A |
5316250 | Mason et al. | May 1994 | A |
D348106 | Mason et al. | Jun 1994 | S |
5323847 | Koizumi et al. | Jun 1994 | A |
5324319 | Mason et al. | Jun 1994 | A |
5324320 | Augustine et al. | Jun 1994 | A |
D348518 | Mason et al. | Jul 1994 | S |
5330519 | Mason et al. | Jul 1994 | A |
5336250 | Augustine | Aug 1994 | A |
5343579 | Dickerhoff et al. | Sep 1994 | A |
5350417 | Augustine | Sep 1994 | A |
D351472 | Mason et al. | Oct 1994 | S |
5352174 | Mason et al. | Oct 1994 | A |
5354117 | Danielson et al. | Oct 1994 | A |
D352781 | Mason et al. | Nov 1994 | S |
5360439 | Dickerhoff et al. | Nov 1994 | A |
5370178 | Agonafer et al. | Dec 1994 | A |
5371665 | Quisenberry et al. | Dec 1994 | A |
D354138 | Kelly | Jan 1995 | S |
D357747 | Kelly | Apr 1995 | S |
5402542 | Viard | Apr 1995 | A |
5405370 | Irani | Apr 1995 | A |
5405371 | Augustine et al. | Apr 1995 | A |
5407421 | Goldsmith | Apr 1995 | A |
D358216 | Dye | May 1995 | S |
5411494 | Rodriguez | May 1995 | A |
5411541 | Bell et al. | May 1995 | A |
5417720 | Mason | May 1995 | A |
5440450 | Lau et al. | Aug 1995 | A |
5449379 | Hadtke | Sep 1995 | A |
5466250 | Johnson, Jr. et al. | Nov 1995 | A |
5496262 | Johnson, Jr. et al. | Mar 1996 | A |
5496357 | Jensen et al. | Mar 1996 | A |
5507792 | Mason | Apr 1996 | A |
5509894 | Mason et al. | Apr 1996 | A |
5514079 | Dillon | May 1996 | A |
5528485 | Devilbiss et al. | Jun 1996 | A |
5561981 | Quisenberry et al. | Oct 1996 | A |
5566062 | Quisenberry et al. | Oct 1996 | A |
5578022 | Scherson et al. | Nov 1996 | A |
5588954 | Ribando et al. | Dec 1996 | A |
5591200 | Cone et al. | Jan 1997 | A |
D380874 | Caswell | Jul 1997 | S |
5648716 | Devilbiss et al. | Jul 1997 | A |
D383546 | Amis et al. | Sep 1997 | S |
D383547 | Mason et al. | Sep 1997 | S |
D383848 | Mason et al. | Sep 1997 | S |
5662695 | Mason et al. | Sep 1997 | A |
5672152 | Mason et al. | Sep 1997 | A |
5675473 | McDunn et al. | Oct 1997 | A |
5682748 | DeVilbiss et al. | Nov 1997 | A |
5689957 | DeVilbiss et al. | Nov 1997 | A |
5690849 | DeVilbiss et al. | Nov 1997 | A |
5711029 | Visco et al. | Jan 1998 | A |
5711155 | DeVilbiss et al. | Jan 1998 | A |
D393073 | Downing et al. | Mar 1998 | S |
5731954 | Cheon | Mar 1998 | A |
5733321 | Brink | Mar 1998 | A |
D394707 | Tsubooka | May 1998 | S |
5755755 | Panyard | May 1998 | A |
5772618 | Mason et al. | Jun 1998 | A |
5782780 | Mason et al. | Jul 1998 | A |
5795312 | Dye | Aug 1998 | A |
5807294 | Cawley et al. | Sep 1998 | A |
5827208 | Mason | Oct 1998 | A |
5831824 | McDunn et al. | Nov 1998 | A |
D403779 | Davis et al. | Jan 1999 | S |
D404490 | Tripolsky | Jan 1999 | S |
D405884 | Roper | Feb 1999 | S |
5865841 | Kolen et al. | Feb 1999 | A |
5890371 | Rajasubramanian et al. | Apr 1999 | A |
5901037 | Hamilton et al. | May 1999 | A |
5923533 | Olson | Jul 1999 | A |
5947914 | Augustine | Sep 1999 | A |
5980561 | Kolen et al. | Nov 1999 | A |
5989285 | DeVilbiss et al. | Nov 1999 | A |
6007559 | Arkans | Dec 1999 | A |
6055157 | Bartilson | Apr 2000 | A |
6058010 | Schmidt et al. | May 2000 | A |
6058712 | Rajasubramanian et al. | May 2000 | A |
6080120 | Sandman et al. | Jun 2000 | A |
D428153 | Davis | Jul 2000 | S |
D430288 | Mason et al. | Aug 2000 | S |
D430289 | Mason et al. | Aug 2000 | S |
6117164 | Gildersleeve et al. | Sep 2000 | A |
6125036 | Kang et al. | Sep 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6176869 | Mason et al. | Jan 2001 | B1 |
6186977 | Andrews et al. | Feb 2001 | B1 |
6235049 | Nazerian | May 2001 | B1 |
6260890 | Mason | Jul 2001 | B1 |
6270481 | Mason et al. | Aug 2001 | B1 |
6295819 | Mathiprakasam et al. | Oct 2001 | B1 |
6305180 | Miller et al. | Oct 2001 | B1 |
6319114 | Nair et al. | Nov 2001 | B1 |
6352550 | Gildersleeve et al. | Mar 2002 | B1 |
6368592 | Colton et al. | Apr 2002 | B1 |
6443978 | Zharov | Sep 2002 | B1 |
6462949 | Parish, IV et al. | Oct 2002 | B1 |
6468237 | Lina | Oct 2002 | B1 |
D472322 | Hoglund et al. | Mar 2003 | S |
D473315 | Miros et al. | Apr 2003 | S |
D473656 | Miros et al. | Apr 2003 | S |
D473948 | Elkins et al. | Apr 2003 | S |
6551264 | Cawley et al. | Apr 2003 | B1 |
D474544 | Hoglund et al. | May 2003 | S |
6562060 | Momtaheni | May 2003 | B1 |
6648904 | Altshuler et al. | Nov 2003 | B2 |
D484601 | Griffiths et al. | Dec 2003 | S |
D484602 | Griffiths et al. | Dec 2003 | S |
6667883 | Solis et al. | Dec 2003 | B1 |
6675072 | Kerem | Jan 2004 | B1 |
D486870 | Mason | Feb 2004 | S |
6695823 | Lina et al. | Feb 2004 | B1 |
6719713 | Mason | Apr 2004 | B2 |
6719728 | Mason et al. | Apr 2004 | B2 |
D492411 | Bierman | Jun 2004 | S |
6775137 | Chu et al. | Aug 2004 | B2 |
D496108 | Machin et al. | Sep 2004 | S |
6789024 | Kochan, Jr. et al. | Sep 2004 | B1 |
6802823 | Mason | Oct 2004 | B2 |
D499846 | Cesko | Dec 2004 | S |
6834712 | Parish et al. | Dec 2004 | B2 |
6848498 | Seki et al. | Feb 2005 | B2 |
6855158 | Stolpmann | Feb 2005 | B2 |
6893414 | Goble et al. | May 2005 | B2 |
6935409 | Parish, IV et al. | Aug 2005 | B1 |
6936019 | Mason | Aug 2005 | B2 |
D510140 | Brown | Sep 2005 | S |
6945988 | Jones | Sep 2005 | B1 |
D510626 | Krahner et al. | Oct 2005 | S |
D515218 | McGuire et al. | Feb 2006 | S |
D523147 | Tesluk | Jun 2006 | S |
7066949 | Gammons et al. | Jun 2006 | B2 |
D533668 | Brown | Dec 2006 | S |
D551351 | Silva | Sep 2007 | S |
D551352 | Frangi | Sep 2007 | S |
D568482 | Gramza et al. | May 2008 | S |
D569985 | Ganapathy et al. | May 2008 | S |
7427153 | Jacobs et al. | Sep 2008 | B1 |
7429252 | Sarangapani | Sep 2008 | B2 |
7492252 | Maruyama | Feb 2009 | B2 |
D595620 | Kingsbury | Jul 2009 | S |
D601707 | Chouiller | Oct 2009 | S |
D608006 | Avitable et al. | Jan 2010 | S |
D612947 | Turtzo et al. | Mar 2010 | S |
D613870 | Shust | Apr 2010 | S |
D618358 | Avitable et al. | Jun 2010 | S |
D619267 | Beckwith et al. | Jul 2010 | S |
D620122 | Cotton | Jul 2010 | S |
D625018 | Smith et al. | Oct 2010 | S |
D626241 | Sagnip et al. | Oct 2010 | S |
D626242 | Sagnip et al. | Oct 2010 | S |
D626243 | Sagnip et al. | Oct 2010 | S |
D626245 | Sagnip et al. | Oct 2010 | S |
D627896 | Matsuo et al. | Nov 2010 | S |
D628300 | Caden | Nov 2010 | S |
D630759 | Matsuo et al. | Jan 2011 | S |
D631971 | Turtzo et al. | Feb 2011 | S |
1003486 | Schaefer | Feb 2011 | A1 |
D633657 | Oban | Mar 2011 | S |
D634437 | Gramza et al. | Mar 2011 | S |
D634851 | Chiang | Mar 2011 | S |
D635266 | Chiang | Mar 2011 | S |
D635267 | Chiang | Mar 2011 | S |
D636497 | Giaccone | Apr 2011 | S |
D638950 | Janzon | May 2011 | S |
D640380 | Tweardy et al. | Jun 2011 | S |
D640381 | Tweardy et al. | Jun 2011 | S |
7959588 | Wolpa | Jun 2011 | B1 |
D649648 | Cavalieri et al. | Nov 2011 | S |
D655420 | Bowles | Mar 2012 | S |
D655821 | Matsuo | Mar 2012 | S |
D657063 | Chiang | Apr 2012 | S |
D660438 | Kennedy et al. | May 2012 | S |
D660439 | Chen et al. | May 2012 | S |
D663850 | Joseph | Jul 2012 | S |
D665088 | Joseph | Aug 2012 | S |
D665470 | Galbraith | Aug 2012 | S |
D666258 | Campbell | Aug 2012 | S |
D666301 | Joseph | Aug 2012 | S |
8444581 | Maxon-Maldonado et al. | May 2013 | B1 |
8449483 | Eddy | May 2013 | B2 |
8485995 | Maxon-Maldonado | Jul 2013 | B1 |
8753300 | Deshpande | Jun 2014 | B2 |
8753383 | Parish et al. | Jun 2014 | B2 |
8827935 | Maxon-Maldonado | Sep 2014 | B2 |
8834393 | Maxon-Maldonado et al. | Sep 2014 | B2 |
20010039439 | Elkins et al. | Nov 2001 | A1 |
20020116041 | Daoud | Aug 2002 | A1 |
20020143373 | Courtnage et al. | Oct 2002 | A1 |
20030050594 | Zamierowski | Mar 2003 | A1 |
20030083610 | McGrath et al. | May 2003 | A1 |
20030089486 | Parish et al. | May 2003 | A1 |
20030089487 | Parish, IV et al. | May 2003 | A1 |
20030127215 | Parish, IV et al. | Jul 2003 | A1 |
20030163183 | Carson | Aug 2003 | A1 |
20030171703 | Grim et al. | Sep 2003 | A1 |
20030176822 | Morgenlander | Sep 2003 | A1 |
20030191437 | Knighton et al. | Oct 2003 | A1 |
20040008483 | Cheon | Jan 2004 | A1 |
20040030281 | Goble et al. | Feb 2004 | A1 |
20040054307 | Mason et al. | Mar 2004 | A1 |
20040068309 | Edelman | Apr 2004 | A1 |
20040068310 | Edelman | Apr 2004 | A1 |
20040099407 | Parish, IV et al. | May 2004 | A1 |
20040133135 | Diana | Jul 2004 | A1 |
20040193218 | Butler | Sep 2004 | A1 |
20040210176 | Diana | Oct 2004 | A1 |
20040221604 | Ota et al. | Nov 2004 | A1 |
20040260231 | Goble et al. | Dec 2004 | A1 |
20050004636 | Noda et al. | Jan 2005 | A1 |
20050006061 | Quisenberry et al. | Jan 2005 | A1 |
20050033390 | McConnell | Feb 2005 | A1 |
20050039887 | Parish, IV et al. | Feb 2005 | A1 |
20050070835 | Joshi | Mar 2005 | A1 |
20050133214 | Pfahnl | Jun 2005 | A1 |
20050177093 | Barry et al. | Aug 2005 | A1 |
20050182364 | Burchman | Aug 2005 | A1 |
20050256556 | Schirrmacher et al. | Nov 2005 | A1 |
20050274120 | Quisenberry et al. | Dec 2005 | A1 |
20050284615 | Parish et al. | Dec 2005 | A1 |
20060058714 | Rhoades | Mar 2006 | A1 |
20060116620 | Oyaski | Jun 2006 | A1 |
20060241549 | Sunnen | Oct 2006 | A1 |
20060282028 | Howard et al. | Dec 2006 | A1 |
20070032778 | Heaton et al. | Feb 2007 | A1 |
20070068651 | Gammons et al. | Mar 2007 | A1 |
20070118194 | Mason et al. | May 2007 | A1 |
20070129658 | Hampson et al. | Jun 2007 | A1 |
20070282249 | Quisenberry | Dec 2007 | A1 |
20080064992 | Stewart et al. | Mar 2008 | A1 |
20080071330 | Quisenberry | Mar 2008 | A1 |
20080082029 | Diana | Apr 2008 | A1 |
20080103422 | Perry et al. | May 2008 | A1 |
20080132816 | Kane et al. | Jun 2008 | A1 |
20080132976 | Kane et al. | Jun 2008 | A1 |
20080262399 | Kovelman et al. | Oct 2008 | A1 |
20080319362 | Joseph | Dec 2008 | A1 |
20090149821 | Scherson et al. | Jun 2009 | A1 |
20090254160 | Shawver et al. | Oct 2009 | A1 |
20100030306 | Edelman et al. | Feb 2010 | A1 |
20100081975 | Avitable et al. | Apr 2010 | A1 |
20100137764 | Eddy | Jun 2010 | A1 |
20100145421 | Tomlinson et al. | Jun 2010 | A1 |
20100150991 | Bernstein | Jun 2010 | A1 |
20100249679 | Perry et al. | Sep 2010 | A1 |
20110009785 | Meyer et al. | Jan 2011 | A1 |
20110071447 | Liu et al. | Mar 2011 | A1 |
20110087142 | Ravikumar et al. | Apr 2011 | A1 |
20110275983 | Quisenberry et al. | Nov 2011 | A1 |
20110282269 | Quisenberry et al. | Nov 2011 | A1 |
20130245508 | Maxon-Maldonado | Sep 2013 | A1 |
20130245519 | Edelman et al. | Sep 2013 | A1 |
20130253383 | Maxon-Maldonado | Sep 2013 | A1 |
20130261512 | Maxon-Maldonado et al. | Oct 2013 | A1 |
20140012169 | Wilford et al. | Jan 2014 | A1 |
Number | Date | Country |
---|---|---|
670 541 | Jun 1989 | CH |
35 22 127 | Jan 1987 | DE |
0 489 326 | Jun 1992 | EP |
2373444 | Sep 2002 | GB |
689674 | Oct 1979 | SU |
WO-9309727 | May 1993 | WO |
WO-0040186 | Jul 2000 | WO |
WO-0114012 | Mar 2001 | WO |
Entry |
---|
U.S. Appl. No. 12/364,434, Quisenberry. |
Artikis, T., PCT International Preliminary Report on Patentability as mailed Jul. 29, 2005, (10 pgs.). |
Tom Lee, T.Y. et al; “Compact Liquid Cooling System for Small, Moveable Electronic Equipment”, IEEE Transactions on Components, Hybrids, and Manufacturing Technology, Oct. 15, 1992, vol. 15, No. 5, pp. 786-793. |
Copenheaver, Blaine R., “International Search Report” for PCT/US2007/022148 as mailed Apr. 2, 2008, 2 pages. |
Young, Lee W., “International Search Report” for PCT/US07/08807 as mailed Mar. 3, 2008, (3 pages). |
Mahmoud Karimi Azar Daryany, et al., “Photoinactivation of Escherichia coli and Saccharomyces cerevisiae Suspended in Phosphate-Buffered Saline-A Using 266- and 355-nm Pulsed Ultraviolet Light”, Curr Microbiol, vol. 56, 2008, pp. 423-428. |
J. Li, et al., “Enhanced germicidal effects of pulsed UV-LED irradiation on biofilms”, Journal of Applied Microbiology, 2010, pp. 1-8. |
Cyro/Temp Therapy Systems; Product News Catalogue; Jobst Institute, Inc., 6 pages (Copyright 1982). |
Quisenberry, Tony, “U.S. Appl. No. 13/359,210,” filed Jan. 26, 2012. |
Quisenberry, Tony, “U.S. Appl. No. 29/424,860,” filed Jun. 15, 2012. |
Quisenberry, Tony, “U.S. Appl. No. 13/456,410,” filed Apr. 26, 2012. |
Copenheaver, Blaine R., “International Search Report” for PCT/US2012/035096 as mailed Aug. 7, 2012, 3 pages. |
Quisenberry, Tony, “U.S. Appl. No. 13/558,615,” filed on Jul. 26, 2012. |
Copenheaver, Blaine R., “International Search Report” prepared for PCT/US2013/030475 as mailed May 23, 2013, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20140249455 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
60817932 | Jun 2006 | US | |
60791132 | Apr 2006 | US | |
60588453 | Jul 2004 | US | |
60550658 | Mar 2004 | US | |
60488709 | Jul 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12234394 | Sep 2008 | US |
Child | 14279449 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11733709 | Apr 2007 | US |
Child | 12234394 | US | |
Parent | 10894369 | Jul 2004 | US |
Child | 11733709 | US |